|
Upper respiratory tract infections
|
Non-polio Enterovirus (NPEV) and Human Parechovirus (HPeV) Molecular Detection and Typing
|
Enteroviruses
|
Enteroviruses and Enteric Viruses
|
|
Upper respiratory tract infections
|
Non-polio Enterovirus (NPEV) and Human Parechovirus (HPeV) Molecular Detection and Typing
|
Parechoviruses
|
Enteroviruses and Enteric Viruses
|
|
Urinary tract infection
|
Hypervirulence
|
Klebsiella pneumoniae
|
Antimicrobial Resistance and Nosocomial Infections
|
|
Urinary tract infection
|
Whole Genome Sequencing (WGS) **Review patient criteria
|
Gram-positive Organisms (VRE, MRSA, C. difficile)
|
Antimicrobial Resistance and Nosocomial Infections
|
|
Urinary tract infection
|
Non-vanA/B VRE Confirmation
|
non-vanA/B Vancomycin-resistant Enterococcus (VRE)
|
Antimicrobial Resistance and Nosocomial Infections
|
|
Urinary tract infection
|
Whole Genome Sequencing (WGS) **Review patient criteria
|
Gram-negative organisms
|
Antimicrobial Resistance and Nosocomial Infections
|
|
Urinary tract infection
|
Resistance Mechanisms
|
Gram-negative organisms
|
Antimicrobial Resistance and Nosocomial Infections
|
|
Urinary tract infection
|
VISA/hVISA Confirmation
|
Staphylococcus aureus
|
Antimicrobial Resistance and Nosocomial Infections
|
|
Urinary tract infection
|
Non-mecA MRSA Confirmation
|
Non-mecA Methicillin-resistant Staphylococcus aureus (MRSA)
|
Antimicrobial Resistance and Nosocomial Infections
|
|
Urinary tract infection
|
Confirmation of Staphylococcal toxins by PCR
|
Staphylococcus aureus
|
Antimicrobial Resistance and Nosocomial Infections
|
|
Urinary tract infection
|
Antimicrobial Susceptibility Testing
|
Gram-negative organisms
|
Antimicrobial Resistance and Nosocomial Infections
|
|
Urinary tract infection
|
Antimicrobial Susceptibility Testing
|
Gram-positive Organisms (VRE, MRSA, C. difficile)
|
Antimicrobial Resistance and Nosocomial Infections
|